What's in Bio Products Laboratory's pipeline?

Bio Products Laboratory has 8 drugs in our index: 5 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Bio Products Laboratory's portfolio?

Top competitors by shared drug class: ADMA Biologics, Inc., Baxalta now part of Shire, Biotest, CSL Behring, CSL Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/bio-products-laboratory.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Bio Products Laboratory — Portfolio Competitive Intelligence Brief

Bio Products Laboratory pipeline: 5 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Gammaplex	Gammaplex	marketed			Other
Human Coagulation FACTOR X	Human Coagulation FACTOR X	marketed
Coagadex	Coagadex	marketed			Other
HyperRAB	HyperRAB	marketed	Rabies immunoglobulin (human)	Rabies virus glycoprotein	Infectious Disease / Immunology
Gammaplex (5%)	Gammaplex (5%)	marketed	Intravenous immunoglobulin (IVIG)	Fc receptors and complement system (indirect mechanism via antibody delivery)	Immunology
Gammaplex 10	Gammaplex 10	phase 3	Intravenous immunoglobulin (IVIG)	Fc receptors; pathogenic antibodies and antigens (non-specific)	Immunology
Subgam	Subgam	phase 3			Other

Therapeutic area mix

Other · 4
Immunology · 2
Infectious Disease / Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADMA Biologics, Inc. · 1 shared drug class
Baxalta now part of Shire · 1 shared drug class
Biotest · 1 shared drug class
CSL Behring · 1 shared drug class
CSL Limited · 1 shared drug class
Grifols Biologicals, LLC · 1 shared drug class
Grifols Therapeutics LLC · 1 shared drug class
Instituto Grifols, S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Bio Products Laboratory:

Cite this brief

Drug Landscape (2026). Bio Products Laboratory — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bio-products-laboratory. Accessed 2026-05-16.